Home - Clinical Trials Arena
Sections. Company A-Z; Company Categories; Products & Services; Company Releases; White Papers; Videos; Buyer's Guides; Partner Content; Latest. Leading sales enablement, …
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials …
Feb 2, 2023 · Although most early clinical research into mRNA vaccines was dominated by institutions and government agencies, the tables have quickly turned. “mRNA technology is …
Phase 0 clinical trials: what you need to know
Jul 21, 2022 · 2021 was a record-breaking year, with more businesses breaking into the billion-dollar club. Many start-ups have achieved or retained the unicorn status by the end of the year …
EU Clinical Trial Regulation: What You Need to Know
May 20, 2021 · The European Medicines Agency (EMA) has announced that its long-delayed clinical trial EU Portal and Database, one of the main features of the Clinical Trial Regulation …
Obesity: Six trials to watch over the next 12 months
Jun 30, 2023 · With an estimated market value of $37.1bn in 2031, the race for the development of obesity medications is on. Here are some trials to watch.
Hepatitis B: Four trials to watch over the next 12 months
Jul 28, 2023 · While Dr Antonio Bertoletti, professor at the Duke-NUS Medical School in Singapore and an infectious disease doctor who has been working on Hepatitis B trials for 30 …
Oral Covid vaccine: can Vaxart overcome clinical trial …
Nov 24, 2021 · Vaxart is aiming to be a vital player in boosting vaccination rates with its oral Covid-19 vaccine. There is still unmet need, with only 53% of the world’s population receiving …
pharmaceutical SMEs take the innovative edge - Clinical …
Apr 18, 2012 · Big Pharma has never been renowned for innovation. Rather, large pharmaceutical companies have traditionally focused on developing and testing conventional therapeutics, …
Vertex Stem Cell Therapy: Potential Breakthrough in …
Oct 19, 2021 · Impressive early results for Vertex’s potentially curative stem cell diabetes therapy. A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its …
BioNTech treats first subject in Phase II cancer vaccine trial
Oct 20, 2023 · BioNTech has treated the first subject in a Phase II clinical trial of cancer vaccine candidate, autogene cevumeran (BNT122, RO7198457) to treat resected pancreatic ductal …